SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Felix B who wrote (3300)6/4/2021 7:26:12 AM
From: Biotechwantabe2 Recommendations

Recommended By
A.J. Mullen
DewDiligence_on_SI

  Read Replies (2) | Respond to of 3557
 
FDA AUTHORIZES LOWER 1,200 MG INTRAVENOUS AND SUBCUTANEOUS DOSE OF REGEN-COV™ (CASIRIVIMAB AND IMDEVIMAB) ANTIBODY COCKTAIL TO TREAT PATIENTS WITH COVID-19

Ask and you shall receive.